Intermediate Capital Group PLC — Proxy Solicitation & Information Statement 2026

Jun 8, 2026

ICG Notice of Annual General Meeting 2026

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspect of the proposals referred to in this document or as to what action to take, you should consult your stockbroker, solicitor, accountant or other appropriate independent professional adviser who, if you are taking advice in the United Kingdom, is authorised under the Financial Services and Markets Act 2000.

If you have sold or otherwise transferred all your shares in ICG PLC, please forward this document and the accompanying Form of Proxy, as soon as possible, to the purchaser or transferee, or to the stockbroker, bank or other agent through whom the sale or transfer was effected, so they can pass these documents to the person who now holds the shares.

The distribution of this document and accompanying documents in or into jurisdictions other than the United Kingdom may be restricted by local law and therefore persons into whose possession this document comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdictions.

ICG

ICG PLC

(Incorporated and registered in England and Wales No. 02234775)

Notice of Annual General Meeting

Notice of the Annual General Meeting of ICG PLC, to be held at 10:00 am on 15 July 2026 at Procession House, 55 Ludgate Hill, London, EC4M 7JW, is set out in this document.

The Form of Proxy for the Annual General Meeting is enclosed and, to be valid, should be completed and returned so as to reach the Company's registrar, Computershare, The Pavilions, Bridgwater Road, Bristol BS99 6ZY as soon as possible and, in any event, so as to arrive by no later than 10:00 am on 13 July 2026. Alternatively, you can register your proxy vote electronically either by means of the website provided by the Company's registrar or, if you are a CREST member, by using the service provided by Euroclear or via Proxymity. Any power of attorney or any other authority under which the Form of Proxy is signed (or a duly certified copy of such power or authority) must be included with the Form of Proxy. Further details are given in the Notes section of this document.

Completion and return of the Form of Proxy will not prevent you from attending and voting at the Annual General Meeting in person, should you choose to do so.

If you have not received the Form of Proxy, please contact the Company's registrar, Computershare, on the helpline telephone number 0370 707 1064 (+44 (0)370 707 1064 if calling from outside the United Kingdom).

---

ICG Notice of Annual General Meeting 2026

Contents

	PAGE	EVENT	EXPECTED TIME/DATE
Timetable of key events	2	Ex-dividend date	11 June 2026
Part I – Letter from the Chair of ICG PLC	3	Record date for Final Dividend	12 June 2026
Part II – Notice of Annual General Meeting	4 to 6	Last date for dividend reinvestment decision	10 July 2026
Notes	7 to 8	Last date and time for submitting Form of Proxy	10:00 am, 13 July 2026
Explanatory notes to the Resolutions	9 to 12	Annual General Meeting	10:00 am, 15 July 2026
Definitions	12	Payment of Final Dividend	31 July 2026

Incorporated and registered in England and Wales, Registration No. 02234775

DIRECTORS

DIRECTORS	REGISTERED OFFICE
William Rucker (Chair)	Procession House
Sonia Baxendale (Independent Non-Executive Director)	55 Ludgate Hill
David Bicarregui (Executive Director)	London
Jonathon Bond (Independent Non-Executive Director)	EC4M 7JW
Benoît Durteste (Executive Director)
Antje Hensel-Roth (Executive Director)
Virginia Holmes (Independent Non-Executive Director)
Robin Lawther (Independent Non-Executive Director)
Rosemary Leith (Independent Non-Executive Director)
Matthew Lester (Independent Non-Executive Director)
Vincent Mortier (Non-Executive Director)
Andrew Sykes (Independent Non-Executive Director and Senior Independent Director)
Stephen Welton (Independent Non-Executive Director)

---

Part I -- Letter from the Chair of ICG PLC

Dear Shareholder,

Notice of Annual General Meeting

I am pleased to be writing to you with details of our Annual General Meeting which will be held at 10:00 am on 15 July 2026 at Procession House, 55 Ludgate Hill, London, EC4M 7JW. The formal notice of the Annual General Meeting is set out later in this document.

The Annual General Meeting is an important event in the Company's corporate calendar and represents the Board's opportunity to present to you the Company's performance and strategic priorities, to engage with you on questions you might raise, as well as to pass the necessary resolutions for the conduct of the business and affairs of the Company.

We will communicate any relevant updates to shareholders on changes to the Annual General Meeting before it is held on the Company's website at www.icgam.com and, where appropriate, by an announcement to the market. Please ensure you check these communication channels before attending.

Voting and proxy appointment

If you hold any existing ordinary shares in the Company, and subject to the arrangements set out in this document, you are entitled to attend and vote at the Annual General Meeting.

If you would like to vote on the resolutions but cannot come to the Annual General Meeting, you can appoint a proxy to exercise all or any of your rights to attend, vote and speak at the Annual General Meeting. Your proxy could be the Chair, another director of the Company or another person who has agreed to attend to represent you. You will find enclosed a Form of Proxy for use at the Annual General Meeting. Instructions in respect of the Form of Proxy can be found on page 7 of this document. The Form of Proxy must be received by the Company's registrar by 10:00 am on 13 July 2026. Any power of attorney or any other authority under which the Form of Proxy is signed (or a duly certified copy of such power or authority) must be included with the Form of Proxy.

Questions

Engagement with our shareholders is important to us. As some shareholders may not be able to attend in person, the Directors encourage shareholders to submit questions they would have raised at the Annual General Meeting by sending them, together with their name as it appears on the Company's register of members, to the following email address: companysecretary@icgplc.com so as to be received no later than 10:00 am on 10 July 2026. Where appropriate and practicable, the Company will endeavour to answer questions received by 10 July 2026 either on the Company's website (www.icgam.com) or in private correspondence. The Company will otherwise provide answers to these questions (where appropriate) during the Annual General Meeting, in private correspondence or on the Company's website.

Shareholders who attend the Annual General Meeting in person will be able to ask questions during the Annual General Meeting. The Notes section of this document provides further guidance on shareholders' rights to ask questions.

The Company's strategic partnership with Amundi

As announced on 18 November 2025, the Company entered into a long-term strategic partnership with Amundi Asset Management S.A.S. (“Amundi”) to develop private markets products managed by the Company and distributed by Amundi to wealth investors. To reinforce the long-term strategic and economic alignment underpinning the partnership, Amundi agreed to acquire a 9.9% economic interest in the Company in a manner that is non-dilutive to the Company's existing shareholders. This interest comprises a mix of ordinary shares acquired on the secondary market and ordinary non-voting shares issued by the Company, accompanied by an on-market share buyback of ordinary shares by the Company. The Company intends to utilise the authorities granted under Resolutions 18, 19 and 21, if approved by shareholders, to facilitate the on-market share buyback programme and Amundi's subscription for ordinary non-voting shares.

Board changes

Since the date of the last Annual General Meeting, there have been a number of Board changes: As announced on 26 February 2025, Robin Lawther, Independent Non-Executive Director of the Company, joined the Board with effect from 1 November 2025.As announced on 19 February 2026, in accordance with the strategic partnership entered into between the Company and Amundi, Vincent Mortier, Non-Executive Director, joined the Board with effect from 31 March 2026.As announced on 10 March 2026, Jonathon Bond, Independent Non-Executive Director, joined the Board with effect from 1 April 2026.

We are delighted to welcome Robin, Vincent and Jonathon to the Board, who will be seeking appointment by shareholders at the Annual General Meeting. Further, as announced on 10 March 2026, as part of ongoing succession planning in respect of Board membership, Stephen Welton and Rosemary Leith will retire from the Board of the Company with effect from the conclusion of the Annual General Meeting and will not be seeking re-appointment at the Annual General Meeting. Sonia Baxendale, who joined the Board of the Company in January 2025, will become Chair of the Risk Committee in succession to Rosemary.

We are grateful to Stephen and Rosemary for their long service and outstanding contributions to the Board and its Committees (including Rosemary's role as Chair of our Risk Committee) during a period of sustained growth and success for ICG. We wish them all the best for the future.

Please see pages 70 and 71 of the Annual Report and Accounts for the profiles of the Directors seeking appointment or re-appointment, as the case may be, at the Annual General Meeting.

Dividend

Shareholders are being asked to approve a Final Dividend of 59.3 pence per share for the financial year ended 31 March 2026. If approved, this Final Dividend will be payable on 31 July 2026 to all shareholders on the register of members of the Company at the close of business on 12 June 2026.

Remuneration Policy

Shareholders are this year being asked to approve a new Directors' Remuneration Policy. Further details are set out in the explanatory notes to Resolution 3.

Explanatory notes and recommendation

Explanatory notes on all the business to be considered at the Annual General Meeting appear on pages 9 to 12 of this document.

The Board considers the proposed Resolutions in the Notice of Annual General Meeting to be in the best interests of the Company and its shareholders as a whole. Accordingly, the Board unanimously recommends that shareholders vote in favour of the Resolutions to be proposed at the Annual General Meeting, as the Directors intend to do in respect of their own beneficial holdings.

If you have any questions in relation to the Annual General Meeting, please contact Andrew Lewis, Company Secretary, at the Company's registered office or on 020 3545 2000.

Yours faithfully,

---

ICG Notice of Annual General Meeting 2026

Part II – Notice of Annual General Meeting

Notice is hereby given that the annual general meeting (the "Annual General Meeting") of ICG PLC (the "Company") will be held at Procession House, 55 Ludgate Hill, London, EC4M 7JW at 10:00 am on 15 July 2026 to consider and, if thought fit, to pass the following Resolutions.

It is intended to propose Resolutions 19 to 22 as special resolutions. All other Resolutions will be proposed as ordinary resolutions. Voting on Resolutions 1 to 22 will be by way of poll rather than a show of hands. This allows the votes of those shareholders who are unable to attend the Annual General Meeting in person to be taken into account. On a poll, every shareholder has one vote for every share held, making it a more democratic way of proceeding. Explanations of the Resolutions are given on pages 9 to 12 of this Notice of Annual General Meeting.

Ordinary resolutions

Resolution 1

1. To receive the Company's financial statements and reports of the Directors of the Company (the "Directors") and of the auditor for the financial year ended 31 March 2026.

Resolution 2

1. To approve the Directors' Remuneration Report (excluding the Directors' Remuneration Policy set out on pages 101 to 108 of the Annual Report and Accounts) as set out on pages 85 to 100 in the annual report and accounts for the financial year ended 31 March 2026 (the "Annual Report and Accounts").

Resolution 3

1. To approve the Directors' Remuneration Policy set out on pages 101 to 108 of the Annual Report and Accounts, to take effect from the date of the Annual General Meeting.

Resolution 4

1. To re-appoint Ernst & Young LLP as auditor of the Company, to hold office from the conclusion of this Annual General Meeting until the conclusion of the next general meeting of the Company at which accounts are laid.

Resolution 5

1. To authorise the Audit Committee, for and on behalf of the Board, to determine the remuneration of the auditors.

Resolution 6

1. To declare a Final Dividend of 59.3 pence per share for the financial year ended 31 March 2026.

Resolution 7

1. To appoint Jonathon Bond as a Director of the Company.

Resolution 8

1. To appoint Robin Lawther as a Director of the Company.

Resolution 9

1. To appoint Vincent Mortier as a Director of the Company.

Resolution 10

1. To re-appoint William Rucker as a Director of the Company.

Resolution 11

1. To re-appoint Sonia Baxendale as a Director of the Company.

Resolution 12

1. To re-appoint David Bicarregui as a Director of the Company.

Resolution 13

1. To re-appoint Benoit Durteste as a Director of the Company.

Resolution 14

1. To re-appoint Antje Hensel-Roth as a Director of the Company.

Resolution 15

1. To re-appoint Virginia Holmes as a Director of the Company.

Resolution 16

1. To re-appoint Matthew Lester as a Director of the Company.

Resolution 17

1. To re-appoint Andrew Sykes as a Director of the Company.

---

ICG Notice of Annual General Meeting 2026
5

Part II – Notice of Annual General Meeting continued

Resolution 18

1. That, in substitution for all existing authorities, the Directors be generally and unconditionally authorised for the purposes of section 551 of the Companies Act 2006 (the "Act"), to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for, or convert any security into, shares in the Company:

a. up to an aggregate nominal amount of £24,855,035; and
b. up to a further aggregate nominal amount of £24,855,035 provided they comprise equity securities (as defined in section 560(1) of the Act) and are offered by way of a fully pre-emptive offer to (i) holders of ordinary shares (other than the Company) on the register of members on a record date fixed by the Directors in proportion (as nearly as may be practicable) to their respective holdings at such date and (ii) other persons so entitled by virtue of the rights attaching to any other equity securities held by them, but subject in both cases to such exclusions or other arrangements as the Directors may deem necessary or appropriate in relation to treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory or any other matter,

such authorities to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 30 September 2027) unless previously renewed, varied or revoked by the Company in general meeting but, in each case, so that the Company may make offers and enter into agreements before the authority expires which would, or might, require shares to be allotted or rights to subscribe for or to convert any security into shares to be granted after the authority expires and the Directors may allot shares or grant such rights under any such offer or agreement as if the authority conferred hereby had not expired. References in this Resolution 18 to the nominal amount of rights to subscribe for or to convert any security into shares (including where such rights are referred to as equity securities as defined in section 560(1) of the Act) are to the nominal amount of shares that may be allotted pursuant to the rights.

Special resolutions

Resolution 19

1. That, in substitution for all existing authorities and subject to the passing of Resolution 18, the Directors be generally empowered pursuant to section 570 of the Companies Act 2006 (the "Act") to allot equity securities (as defined in section 560(1) of the Act) for cash pursuant to the authority granted by Resolution 18 or pursuant to section 573 of the Act to sell shares held by the Company as treasury shares for cash, in each case free of the restriction in section 561 of the Act, such authority to be limited:

a. to the allotment of equity securities or sale of treasury shares for cash in connection with an offer of or invitation to apply for equity securities (but in the case of an allotment pursuant to the authority granted by paragraph (b) of Resolution 18, such authority shall be limited to the allotment of equity securities by way of a fully pre-emptive offer only) to (i) holders of ordinary shares (other than the Company) on the register of members on a record date fixed by the Directors in proportion (as nearly as may be practicable) to their respective holdings at such date and (ii) other persons so entitled by virtue of the rights attaching to any other equity securities held by them, but subject in both cases to such exclusions or other arrangements as the Directors may deem necessary or appropriate in relation to treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory or any other matter;
b. to the allotment of equity securities pursuant to the authority granted by paragraph (a) of Resolution 18 or sale of treasury shares for cash (in each case otherwise than under paragraph (a) or paragraph (c) of this Resolution 19) up to an aggregate nominal amount of £7,456,510, being 10% of the issued ordinary share capital of the Company (excluding treasury shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice) (calculated, in the case of equity securities which are rights to subscribe for, or to convert securities into, ordinary shares, by reference to the aggregate nominal amount of relevant shares which may be allotted pursuant to such rights); and
c. to the allotment of equity securities or sale of treasury shares for cash (in each case otherwise than under paragraph (a) or paragraph (b) of this Resolution 19) up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph (b) of this Resolution 19, such authority to be used only for the purposes of making a follow-on offer which the Directors determine to be of a kind contemplated by paragraph 3 of Part 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice,

such authorities to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 30 September 2027) unless previously renewed, varied or revoked by the Company in general meeting but, in each case, so that the Company may make offers and enter into agreements before the authority expires which would, or might, require equity securities to be allotted (or treasury shares to be sold) after the authority expires and the Directors may allot equity securities (or sell treasury shares) under any such offer or agreement as if the authority conferred hereby had not expired.

---

ICG Notice of Annual General Meeting 2026

Part II – Notice of Annual General Meeting continued

Resolution 20

1. That, in addition to any authority granted under Resolution 19, and subject to the passing of Resolution 18, the Directors be generally empowered pursuant to section 570 of the Companies Act 2006 (the "Act") to allot equity securities (as defined in section 560(1) of the Act) for cash pursuant to the authority granted by Resolution 18 or pursuant to section 573 of the Act to sell shares held by the Company as treasury shares for cash, in each case free of the restriction in section 561 of the Act, such authority to be limited:

a. to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of £7,456,510, being 10% of the issued ordinary share capital of the Company (excluding treasury shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice) (calculated, in the case of equity securities which are rights to subscribe for, or to convert securities into, ordinary shares, by reference to the aggregate nominal amount of relevant shares which may be allotted pursuant to such rights) such authority to be used only for the purposes of financing (or refinancing, if the authority is to be used within 12 months after the original transaction) a transaction which the Directors of the Company determine to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice, or any other purposes as the Company in general meeting may at any time by special resolution determine; and

b. to the allotment of equity securities or sale of treasury shares for cash (in each case otherwise than under paragraph (a) of this Resolution 20) up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph (a) of this Resolution 20, such authority to be used only for the purposes of making a follow-on offer which the Directors determine to be of a kind contemplated by paragraph 3 of Part 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice,

such authorities to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 30 September 2027) unless previously renewed, varied or revoked by the Company in general meeting but, in each case, so that the Company may make offers and enter into agreements before the authority expires which would, or might, require equity securities to be allotted (or treasury shares to be sold) after the authority expires and the Directors may allot equity securities (or sell treasury shares) under any such offer or agreement as if the authority conferred hereby had not expired.

Resolution 21

1. That the Company be generally and unconditionally authorised for the purposes of section 701 of the Companies Act 2006 (the "Act") to make one or more market purchases (within the meaning of section 693(4) of the Act) of ordinary shares of 26½p in the capital of the Company provided that:

a. the maximum aggregate number of ordinary shares authorised to be purchased is 28,405,754 (representing 10% of the issued ordinary share capital of the Company (excluding treasury shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice));
b. the minimum price (excluding expenses) which may be paid for an ordinary share is 26½p, being the nominal value of that share;
c. the maximum price (excluding expenses) which may be paid for an ordinary share shall be the higher of (1) an amount equal to 105% of the average of the middle market quotations for an ordinary share as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which that ordinary share is purchased and (2) the higher of the price of the last independent trade and the highest current independent bid for an ordinary share on the trading venue where the purchase is carried out;
d. this authority expires at the conclusion of the next annual general meeting of the Company (or, if earlier, the close of business on 30 September 2027); and
e. the Company may make a contract to purchase ordinary shares under this authority before the expiry of the authority which will or may be executed wholly or partly after the expiry of the authority, and may make a purchase of ordinary shares in pursuance of any such contract.

Resolution 22

1. To authorise the Directors to call a general meeting of the Company other than an annual general meeting on not less than 14 clear days' notice.

By order of the board

Andrew Lewis
Company Secretary
28 May 2026

Registered Office:
Procession House
55 Ludgate Hill
London
EC4M 7JW

Registered in England and Wales No. 02234775

---

Notes

The following notes explain your general rights as a shareholder and your rights to attend and vote at the Annual General Meeting or to appoint someone else to vote on your behalf.

Proxies

A shareholder is entitled to appoint another person as their proxy to exercise all or any of their rights to attend, to speak and to vote on their behalf at the Annual General Meeting. A shareholder may appoint more than one proxy in relation to the Annual General Meeting, provided that each proxy is appointed to exercise the rights attached to a different share or shares held by them. A proxy need not be a shareholder of the Company. Your proxy could be the Chair, another director of the Company or another person who has agreed to attend to represent you. A Form of Proxy which may be used to make such appointment and give proxy instructions accompanies this Notice.

To be valid, Forms of Proxy or other instruments appointing a proxy need to be received by post or by hand (during normal business hours only) by the Company's registrar, Computershare, The Pavilions, Bridgwater Road, Bristol BS99 6ZY, in each case not later than 10:00 am on 13 July 2026 (or, if the Annual General Meeting is adjourned, 48 hours before the time of the adjourned meeting). Only working days shall be taken into account in calculating this time period. Any power of attorney or any other authority under which the Form of Proxy is signed (or a duly certified copy of such power or authority) must be included with the Form of Proxy. Completion of a Form of Proxy (or electronic proxy appointment or any BLAST Proxy Instruction or Proxymity Instruction, each as defined and further outlined below) will not preclude a shareholder attending and voting in person at the Annual General Meeting, or any adjournment thereof.

Joint holders

If two or more persons are joint holders of a share, then in voting on any Resolution or question the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders. Seniority is determined by the order in which the names of the joint holders appear in the Company's register of members (the first-named being the most senior).

Electronic proxies

As an alternative to completing and returning the printed Form of Proxy, you may submit your proxy electronically by accessing www. investorcentre.co.uk/eproxy. For security purposes, shareholders will need to provide their control number, shareholder reference number (“SRN”) and personal identification number (“PIN”) to validate the submission of their proxy online. Shareholders' individual control, SRN and PIN numbers are shown on the printed Form of Proxy. For further information, see the instructions printed on the Form of Proxy. If a shareholder wishes to appoint more than one proxy, the shareholder should contact the Computershare Contact Centre on telephone number 0370 707 1064 (or +44 (0)370 707 1064 if calling from outside the United Kingdom) to obtain an additional Form of Proxy. Your Form of Proxy must be received by the Company's registrar no later than 10:00 am on 13 July 2026 (or, if the Annual General Meeting is adjourned, 48 hours before the time of the adjourned meeting). Only working days shall be taken into account in calculating this time period.

CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the Annual General Meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual (available via www.euroclear.com). CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.

In order for a proxy appointment or instruction made using the CREST service to be valid, the appropriate CREST message (a “CREST Proxy Instruction”) must be properly authenticated in accordance with Euroclear's specifications and must contain the information required for such instructions, as described in the CREST Manual.

The message, regardless of whether it constitutes the appointment of a proxy or an amendment to the instruction given to a previously appointed proxy, must, in order to be valid, be transmitted so as to be received by the issuer's agent (ID 3RA50) by the latest time for receipt of proxy appointments specified in this Notice. For this purpose, the time of receipt will be taken to be the time (as determined by the time stamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time, any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.

CREST members and, where applicable, their CREST sponsors or voting service provider(s) should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions.

It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his/her CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this regard, CREST members and, where applicable, their CREST sponsors or voting service provider(s) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.

Proxymity voting

Institutional investors may also be able to appoint a proxy electronically via the Proxymity platform (“Proxymity Instruction”); a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io. A Proxymity Instruction must be received by 10:00 am on 13 July 2026 in order to be valid (or, if the Annual General Meeting is adjourned, 48 hours before the time of the adjourned meeting). Only working days shall be taken into account in calculating this time period. Before mailing a Proxymity Instruction, you will need to accept Proxymity's associated terms and conditions, which will govern any Proxymity Instruction.

Documents on display

Copies of the following documents are available for inspection at the Company's registered office during normal business hours from the date of this Notice until the close of the Annual General Meeting (Saturdays, Sundays and public holidays excepted), and will be available for inspection at the place of the Annual General Meeting for at least 15 minutes prior to and during the Annual General Meeting:

• Directors' service agreements;
• terms and conditions of appointment of Non-Executive Directors; and
• Directors' deeds of indemnity.

If any shareholder is unable to attend the offices but wishes to receive a copy or raise a question in respect of these documents, they should contact the Company Secretary on companysecretary@icgplc.com.

---

Notes continued

Right to attend and vote

Pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001 and section 360B(2) of the Act, the Company specifies that in order to have the right to attend and vote at the Annual General Meeting (and also for the purpose of determining how many votes a person entitled to attend and vote may cast), a person must be entered on the register of members of the Company at 6:00 pm on 13 July 2026 or, in the event of any adjournment, at 6:00 pm on the date which is two working days before the day of the adjourned meeting. A holder of ordinary non-voting shares shall not be entitled to receive notice of the Annual General Meeting nor to attend, speak or vote at the Annual General Meeting.

Changes to entries on the register of members after this time will be disregarded in determining the rights of any person to attend or vote at the Annual General Meeting.

Corporate shareholders

Any corporation which is a shareholder can appoint one or more corporate representatives who may exercise on its behalf all of its powers as a shareholder provided that no more than one corporate representative exercises powers over the same shares.

Nominated persons

Any person to whom this Notice is sent who is a person nominated under section 146 of the Act to enjoy information rights (a “Nominated Person”) may have a right, under an agreement between them and the shareholder by whom they were nominated, to be appointed (or to have someone else appointed) as a proxy for the Annual General Meeting. If a Nominated Person has no such proxy appointment right or does not wish to exercise it, they may have a right, under such an agreement, to give instructions to the shareholder as to the exercise of voting rights. The statement of the above rights of the shareholders in relation to the appointment of proxies does not apply to Nominated Persons. Those rights can only be exercised by shareholders of the Company.

Website publication of audit concerns

Shareholders should note that it is possible that under section 527 of the Act, shareholders meeting the threshold requirements under that section have the right to require the Company to publish on a website a statement setting out any matter relating to: (i) the audit of the Company's accounts (including the auditor's report and the conduct of the audit) that are to be laid before the Annual General Meeting; or (ii) any circumstance connected with an auditor of the Company ceasing to hold office since the previous meeting at which annual accounts and reports were laid in accordance with section 437 of the Act, (in each case) that the shareholders propose to raise at the Annual General Meeting. The Company may not require the shareholders requesting any such website publication to pay its expenses in complying with sections 527 or 528 of the Act. Where the Company is required to place a statement on a website under section 527 of the Act, it must forward the statement to the Company's auditor not later than the time when it makes the statement available on the website. The business which may be dealt with at the Annual General Meeting includes any statement that the Company has been required under section 527 of the Act to publish on a website.

Requisition rights

Under sections 338 and 338A of the Act, shareholders meeting the threshold requirements in those sections have the right to require the Company: (i) to give, to shareholders of the Company entitled to receive notice of the Annual General Meeting, notice of a resolution which those shareholders intend to move (and which may properly be moved) at the Annual General Meeting; and (ii) to include in the business to be dealt with at the Annual General Meeting any matter (other than a proposed resolution) which may properly be included in the business at the Annual General Meeting, provided in each case that the requirements of those sections are met and that the request is received by the Company not later than six clear weeks before the Annual General Meeting or, if later, the time at which notice is given of the Annual General Meeting.

Total number of shares and voting rights

As at 19 May 2026 (being the latest practicable date prior to publication of this Notice) the Company's issued share capital consists of 294,373,624 ordinary shares with a nominal value of 26½p each and carrying one vote each, and 3,951,459 ordinary non-voting shares with a nominal value of 26½p each which carry no right to vote. As at 19 May 2026, the Company held 10,316,078 ordinary shares in treasury, in respect of which it does not exercise any votes. Accordingly, the total voting rights in the Company as at 19 May 2026 was 284,057,546.

Questions

Any shareholder attending the Annual General Meeting has the right to ask questions. In addition, the Company is giving shareholders who are not attending the Annual General Meeting in person the opportunity to submit questions in advance of the Annual General Meeting by email to companysecretary@icgplc.com. If asking a question in advance, please confirm your name as it appears in the Company's register of members in the email. Questions should be received no later than 10:00 am on 10 July 2026. Where appropriate and practicable, the Company will endeavour to answer questions received by 10 July 2026 either on the Company's website (www.icgam.com) or through private correspondence. The Company will otherwise provide answers to these questions (where appropriate) during the Annual General Meeting, in private correspondence or on our website.

The Company must cause to be answered any such question relating to the business being dealt with at the Annual General Meeting but no such answer need be given if: (a) to do so would interfere unduly with the preparation for the Annual General Meeting or involve the disclosure of confidential information; (b) the answer has already been given on a website in the form of an answer to a question; or (c) it is undesirable in the interests of the Company or the good order of the Annual General Meeting that the question be answered.

Use of electronic addresses

You may not use any electronic address (within the meaning of section 333(4) of the Act) provided in this Notice (or in any related documents including the covering letter and Form of Proxy) to communicate with the Company for any purposes other than those expressly stated.

Website information

A copy of this Notice, and other information required by section 311A of the Act, can be found at www.icgam.com.

Data protection

The Company may process the personal data of attendees at the Annual General Meeting. This may include photos, recordings, audio and video links, as well as other forms of personal data. The Company shall process any such personal data in accordance with its privacy policy, which can be accessed on the Company's website at www.icgam.com/policies/privacy.

Security

We do not permit behaviour that may interfere with anyone's security or safety or the good order of the meeting. Anyone who behaves in a manner which the Chair of the Annual General Meeting considers compromises anyone's security or safety or the good order of the meeting may be removed from the meeting.

---

Explanatory notes to the Resolutions

The explanatory notes that follow form part of the Notice of Annual General Meeting and provide important information regarding the items of business to be considered at the Annual General Meeting.

Resolutions 19 to 22 will be proposed as special resolutions. All other Resolutions will be proposed as ordinary resolutions. To pass special resolutions at least 75% of the votes cast must be in favour of the Resolution, while, in the case of ordinary resolutions, more than 50% of the votes cast must be in favour of the Resolution. Voting on Resolutions 1 to 22 will be undertaken by way of a poll. The results of the polls will be announced as soon as practicable and will appear on the Company's website (www.icgam.com).

Resolution 1 -- Annual Report and Accounts

The Act requires the directors of a public company to lay before the company in a general meeting copies of the directors' reports, the independent auditor's report and the audited accounts of the company. In line with best practice, shareholders are asked to receive the Annual Report and Accounts.

The Annual Report and Accounts will be mailed by 8 June 2026 to those shareholders who have elected to receive it in hard copy form. From 8 June 2026 any shareholder may access the Annual Report and Accounts on the Company's website (www.icgam.com) or may obtain a hard copy on application to the Company Secretary at Procession House, 55 Ludgate Hill, London, EC4M 7JW or to companysecretary@icgplc.com.

Resolution 2 -- Directors' Remuneration Report

Resolution 2 seeks shareholder approval for the Directors' Remuneration Report (other than the Directors' Remuneration Policy) which is set out on pages 85 to 100 of the Annual Report and Accounts and provides details of Directors' remuneration for the year ended 31 March 2026. This Resolution is an advisory vote, as provided by law, meaning that the Directors' entitlements to remuneration are not conditional upon the Resolution being passed.

Resolution 3 -- Directors' Remuneration Policy

Resolution 3 seeks shareholder approval of the Directors' Remuneration Policy which is set out on pages 101 to 108 of the Annual Report and Accounts (the “Policy”).

The Remuneration Committee undertook a review of the Policy in preparation for this normal triennial vote and consulted extensively with the Company's major shareholders on the proposed changes. Under the proposed Policy, the overall structure of remuneration for Executive Directors remains unchanged, as it is clear and simple, designed to drive sustained high performance, and aligned to shareholders' interests. The key changes in the proposed Policy are an increase in the maximum variable pay that the Remuneration Committee can award for outstanding performance, and an increase in the Minimum Shareholding Requirement that applies to Executive Directors whilst in post and for two years after cessation of role. The Company has grown, developed and diversified substantially over the last eight years since the current Chief Executive Officer and Chief Investment Officer was appointed, but the maximum variable remuneration for this role has not changed over this period. Most of the companies in the international alternative asset management sector in which the Company competes for clients and for leadership talent are listed or headquartered in North America. The proposed Policy is designed to assist the Company in competing with its international peer group, by bringing the Company's maximum remuneration for exceptional Executive Director performance closer to the mid-market levels amongst its competitors.

The vote on Resolution 3 is binding in nature and, if approved, the revised Policy will take effect from the end of the Annual General Meeting. Once the Policy has been approved, the Company may not make a remuneration payment or payment for loss of office to a Director or former Director of the Company unless that payment is consistent with the approved Policy, or has otherwise been approved by a shareholder resolution. If the Policy is not approved, the Directors' Remuneration Policy approved at the 2023 annual general meeting will continue to apply. The Directors' Remuneration Policy will next be submitted to shareholders no later than the annual general meeting of the Company to be held in 2029.

Resolutions 4 and 5 -- Re-appointment and remuneration of the auditors

At each general meeting at which the accounts are laid before its shareholders, the Company is required to appoint an auditor to hold office until the end of the next such meeting. Ernst & Young LLP has indicated that it is willing to continue as the Company's auditor for another year and Resolution 4 is, therefore, to re-appoint Ernst & Young LLP as auditor for the financial year ending 31 March 2027. The proposal to re-appoint Ernst & Young LLP as the Company's auditor is based on a recommendation from the Audit Committee, is free from third party influence and is not subject to any restrictive contractual arrangements. Separately, Resolution 5 seeks shareholder approval for the Audit Committee (for and on behalf of the Board) to be authorised to determine the remuneration of the Company's auditors.

Resolution 6 -- Final dividend

Resolution 6 seeks shareholder approval for a Final Dividend for the year ended 31 March 2026 of 59.3 pence per share which is recommended by the Directors. If approved by the shareholders, the dividend will be paid on 31 July 2026 to all shareholders on the register of members of the Company at the close of business on 12 June 2026.

Resolutions 7 to 17 -- Appointment and re-appointment of Directors

In accordance with the UK Corporate Governance Code and the Company's Articles of Association, each of William Rucker, Sonia Baxendale, David Bicarregui, Benoît Durteste, Antje Hensel-Roth, Virginia Holmes, Matthew Lester, and Andrew Sykes will offer themselves for re-appointment at the Annual General Meeting. Jonathon Bond, Robin Lawther and Vincent Mortier will be seeking appointment by shareholders at the Annual General Meeting.

The Board is satisfied that each of the Directors proposed for appointment or re-appointment (as the case may be) has the appropriate balance of skills, experience, independence and knowledge of the Company to enable them to discharge the duties and responsibilities of a Director effectively. Furthermore, following performance review, each Director subject to re-appointment continues to make an effective and valuable contribution and demonstrates commitment to their role. The Board considers all of its Independent Non-Executive Directors to be independent in character and judgement. Accordingly, the Board unanimously recommends the appointment or re-appointment (as the case may be) of these Directors.

Virginia Holmes was appointed to the Board in March 2017 and will therefore have served on the Board for over nine years by the time of the 2026 AGM. As further explained in the Annual Report and Accounts, having given careful consideration to the matter, the Board considers that Virginia continues to be independent and demonstrates clear independence of character and judgement and that her continued membership of the Board is in the best interests of the Company.

Biographical information relating to each of the Directors standing for appointment or re-appointment (as the case may be), including the specific reasons why their contribution is, and continues to be, important for the Company's long-term sustainable success, appears on pages 70 and 71 of the Annual Report and Accounts.

---

ICG Notice of Annual General Meeting 2026

Explanatory notes to the Resolutions continued

Resolution 18 – Allotment of shares

Resolution 18 seeks shareholder approval to renew the Directors' authority to allot shares.

The Investment Association's share capital management guidelines (as updated in February 2023) (the "IA Guidelines") state that its members will permit, and treat as routine, resolutions seeking authority to allot shares representing up to two thirds of the Company's issued share capital. The IA Guidelines provide that any routine authority to allot shares representing in excess of one third of the Company's issued share capital should only be used to allot shares pursuant to a fully pre-emptive offer.

In accordance with the IA Guidelines, the Board seeks shareholders' authority to allot shares in the capital of the Company up to a maximum nominal amount of £49,710,070, representing approximately two thirds of the Company's issued ordinary share capital (excluding treasury shares and ordinary non-voting shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice). Of this amount, £24,855,035 (representing approximately one third of the Company's issued ordinary share capital (excluding treasury shares and ordinary non-voting shares)) can only be allotted pursuant to a fully pre-emptive offer.

The authority granted at the last annual general meeting is due to expire at the Annual General Meeting. It is the Company's policy to seek renewal of these authorities annually and the authorities sought under paragraphs (a) and (b) of this Resolution will expire at the conclusion of the next annual general meeting of the Company (or, if earlier, at the close of business on 30 September 2027).

In accordance with the strategic partnership between the Company and Amundi, as announced on 18 November 2025, the Company is currently utilising the authority it obtained to allot shares at the 2025 annual general meeting to allot ordinary non-voting shares in the capital of the Company to Amundi, in a manner that is non-dilutive to the Company's existing shareholders. The subscription price for such ordinary non-voting shares is and will be equal to the price paid by the Company for the ordinary shares repurchased by the Company pursuant to the on-market share buyback programme from time to time, as announced on 19 February 2026.

As at 19 May 2026 (being the latest practicable date prior to publication of this Notice), the Company had issued a total of 3,951,459 ordinary non-voting shares, under the authority granted by shareholders at the 2025 annual general meeting. The Company may issue up to a further 8,698,080 ordinary non-voting shares under the terms of the Subscription Agreement, between the Company and Amundi. As such, the Company intends to utilise the authority under this Resolution, if passed, to issue the ordinary non-voting shares.

The Directors have no present intention of exercising this authority other than in connection with the allotment of ordinary non-voting shares to Amundi, as described above. However, the Directors consider it appropriate to maintain the flexibility that this authority provides to respond to market developments and to enable allotments to take place to finance business opportunities as they arise.

As at 19 May 2026 (being the latest practicable date prior to publication of this Notice), the Company is holding 10,316,078 shares in treasury representing 3.63% of the Company's issued ordinary share capital (excluding treasury shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice).

Resolutions 19 and 20 (Special resolutions) – General and additional powers to disapply pre-emption rights

If the Directors wish to allot new shares and other equity securities, or sell treasury shares, for cash (other than in connection with an employee share scheme), they must, in the first instance, offer them to shareholders in proportion to their existing holdings in accordance with the Act, unless shareholders have given their prior approval to do otherwise.

Resolutions 19 and 20, which are each proposed as special resolutions, seek to replace the powers given to the Directors at the Company's annual general meeting last year, which would otherwise expire at the Annual General Meeting, to allot equity securities, or sell treasury shares, for cash in certain circumstances without first offering them to existing shareholders in accordance with the Act, up to a maximum of 24% of the Company's issued share capital (excluding treasury shares and ordinary non-voting shares).

Resolution 19 empowers Directors to allot new shares, or to sell treasury shares, for cash without the shares first being offered to shareholders in proportion to their existing holdings in accordance with the Act:

(a) under paragraph (a) of Resolution 19, for allotments or sales for cash in connection with offers to existing shareholders subject to any adjustments, such as for fractional entitlements and overseas shareholders, as the Directors see fit;

(b) under paragraph (b) of Resolution 19, up to an aggregate nominal amount of £7,456,510, equivalent to approximately 10% of the total issued ordinary share capital of the Company (excluding treasury shares and ordinary non-voting shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice); and

(c) under paragraph (c) of Resolution 19, up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph (b) of Resolution 19, such power to be used only for the purposes of a follow-on offer as described in the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice (the "Pre-Emption Group Principles").

In accordance with the strategic partnership between the Company and Amundi, as announced on 18 November 2025, the Company is currently utilising the authority it obtained to disapply pre-emption rights at the 2025 annual general meeting to allot ordinary non-voting shares in the capital of the Company to Amundi, in a manner that is non-dilutive to the Company's existing shareholders. The subscription price for such ordinary non-voting shares will be equal to the price paid by the Company for the ordinary shares repurchased by the Company pursuant to the on-market share buyback programme, announced on 19 February 2026.

As at 19 May 2026 (being the latest practicable date prior to publication of this Notice), the Company had issued a total of 3,951,459 ordinary non-voting shares, under the authority granted by shareholders at the 2025 annual general meeting. The Company may issue up to a further 8,698,080 ordinary non-voting shares under the terms of the Subscription Agreement, between the Company and Amundi. As such, the Company intends to utilise the authority under this Resolution, if passed, to issue the ordinary non-voting shares.

---

Explanatory notes to the Resolutions continued

Resolution 20 additionally empowers Directors to allot new shares, or to sell treasury shares, for cash, without the shares first being offered to existing shareholders in proportion to their existing holdings in accordance with the Act, in connection with the financing (or refinancing, if the power is to be used within 12 months after the original transaction) of an acquisition or specified capital investment which is announced contemporaneously with the allotment or which has taken place in the preceding 12 month period and is disclosed in the announcement of the allotment. The power under Resolution 20 is limited to:

1. up to an aggregate nominal amount of £7,456,510, equivalent to approximately 10% of the nominal amount of the total issued ordinary share capital of the Company (excluding treasury shares and ordinary non-voting shares) as at 19 May 2026 (being the latest practicable date prior to publication of this Notice); and
2. up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph 1 of Resolution 20, such power to be used only for the purposes of a follow-on offer as described in the Pre-Emption Group Principles.

The Directors confirm that they will only allot shares for cash pursuant to the power referred to in Resolution 20 where that allotment is in connection with an acquisition or a specified capital investment (as defined in the Pre-Emption Group Principles) which is announced contemporaneously with the allotment, or which has taken place in the preceding 12 month period and is disclosed in the announcement of the allotment.

The power sought by the Directors in both Resolution 19 and Resolution 20 includes the ability to issue up to a further 2% of issued ordinary share capital (excluding treasury shares and ordinary non-voting shares) in each case for the purposes of a follow-on offer. The Pre-Emption Group Principles provide for follow-on offers as a possible means of enabling smaller and retail shareholders in the Company to participate in a non-pre-emptive equity issue when it may not be possible (for timing or other reasons) for them to participate in a particular placing being undertaken. The Pre-Emption Group Principles set out the expected features of any such follow-on offer, including in relation to qualifying shareholders, monetary caps on the amount qualifying shareholders can subscribe and the issue price of the shares.

For the purposes of the UK Listing Rules disclosure requirement in relation to the maximum amount of the Company's equity securities (which for these purposes is the combined total of ordinary shares, ordinary non-voting shares and treasury shares) that the disapplication authority will cover, that figure is 22.85% as at 19 May 2026 (being the latest practicable date prior to publication of this Notice).

Resolutions 19 and 20 are in line with institutional shareholder guidance and in particular, with the Pre-Emption Group Principles and the IA Guidelines. The Directors have no present intention to exercise these authorities other than in connection with the allotment of ordinary non-voting shares to Amundi, as described above. However, the Directors consider it desirable to have the maximum flexibility permitted by institutional guidelines to respond to market developments and to enable allotments to take place to finance business opportunities without making a pre-emptive offer to existing shareholders.

The Directors confirm their intention to follow the shareholder protections set out in paragraph 1 of Part 2B of the Pre-Emption Group Principles as well as the expected features of a follow-on offer as set out in paragraph 3 of Part 2B of the Pre-Emption Group Principles if they were to exercise the powers granted by Resolutions 19 and 20.

If the Resolutions are passed, the powers will expire at the conclusion of the next annual general meeting of the Company (or, if earlier, at the close of business on 30 September 2027). The Directors intend to seek renewal of these powers at each annual general meeting of the Company.

Resolution 21 (Special resolution) -- Repurchase of own shares

Resolution 21, proposed as a special resolution, seeks shareholder approval to authorise the Company to make market purchases of its own shares for up to 28,405,754 shares, representing approximately 10% of the total issued ordinary share capital (excluding treasury shares and ordinary non-voting shares) of the Company as at 19 May 2026 (being the latest practicable date prior to publication of this Notice). The Resolution specifies the minimum and maximum prices at which such shares may be purchased under this authority.

As announced on 18 November 2025, the Company entered into a long-term strategic partnership with Amundi. To reinforce the long-term strategic and economic alignment that underpins this partnership, Amundi agreed to acquire and hold ordinary shares in the Company representing approximately 4.64% of the Company's issued share capital. In addition, Amundi agreed to subscribe for ordinary non-voting shares in the capital of the Company representing approximately 5.26% of the aggregate issued capital of Company, such that Amundi's overall non-dilutive economic interest in the Company will represent approximately 9.9%. As a pre-condition to ensure that the issue of the ordinary non-voting shares is non-dilutive to the Company's existing shareholders, the Company agreed to undertake an on-market share buyback of ordinary shares representing approximately 5.26% of the Company's issued share capital.

The Company is currently utilising the authority it obtained at the 2025 annual general meeting to undertake the on-market share buyback programme to purchase a maximum number of 15,280,825 ordinary shares with a maximum aggregate value of up to £316 million, as announced on 19 February 2026. To facilitate the share buyback programme, the Company has entered into an engagement letter with Merrill Lynch International (“BofA Securities”) pursuant to which the Company has issued an instruction providing BofA Securities with the authority to repurchase ordinary shares in the Company subject to certain agreed parameters.

As at 19 May 2026 (being the latest practicable date prior to publication of this Notice), the Company had purchased a total of 6,582,745 ordinary shares under the authority granted by shareholders at the 2025 annual general meeting. The ordinary shares were purchased at a weighted average price of £16.91 per share for a total consideration of £111,339,527, representing 2.32% of the Company's issued ordinary share capital (excluding any treasury shares and ordinary non-voting shares). The shares purchased were placed in treasury and will, in due course, be cancelled in tranches on at least a bi-annual basis, and will not be used for any other purpose prior to cancellation.

Up to 8,698,080 ordinary shares remain to be repurchased pursuant to the share buyback programme. The share buyback programme is expected to end no later than 30 June 2027. As such, the Company intends to utilise the authority under this Resolution, if passed, to continue to undertake the on-market share buyback programme.

The Company will only exercise this authority to purchase shares in the market after careful consideration by the Directors (taking into account market conditions, other investment opportunities, appropriate gearing levels and the overall financial position of the Company) and in circumstances where to do so would be in the best interests of shareholders generally.

---

ICG Notice of Annual General Meeting 2026

Explanatory notes to the Resolutions continued

The Directors intend that any shares purchased in the market pursuant to the share buyback programme as announced on 19 February 2026 will be held in treasury and will, in due course, be cancelled in tranches on at least a bi-annual basis, and will not be used for any other purpose prior to cancellation. Further, the Directors currently intend that any other shares purchased in the market under this authority will be held as treasury shares, which may then be sold for cash. However, the Company may, as permitted by company law, instead cancel those shares. In determining whether to hold the shares in treasury or cancel them, the Directors will take into account the Company's capital requirements and prevailing market conditions at the time of any and each actual purchase. Whilst held in treasury, the shares are not entitled to receive any dividends and have no voting rights.

As at 19 May 2026 (being the latest practicable date prior to publication of this Notice), the Company had 952,453 options outstanding over the Company's shares, representing approximately 0.34% of the Company's issued share capital (excluding the 10,316,078 ordinary shares held in treasury as at 19 May 2026). If the existing authority given at the Company's annual general meeting last year and the authority now being sought by this Resolution were to be exercised in full, these options (assuming no further shares are issued after the latest practicable date prior to publication of this Notice) would represent approximately 2.02% of the Company's issued share capital at that date (excluding the 10,316,078 ordinary shares held in treasury as at the latest practicable date prior to publication of this Notice). The Company has no warrants in issue in relation to its shares.

If approved, this authority will expire at the conclusion of the next annual general meeting of the Company (or, if earlier, at the close of business on 30 September 2027). The Directors currently intend to seek renewal of this authority at each annual general meeting of the Company.

Resolution 22 (Special resolution) - Calling a general meeting on short notice

Under the Act, general meetings must be held on 21 clear days' notice unless shareholders approve a shorter notice period, which cannot, however, be less than 14 clear days' notice. Shareholders should note that under the Act, in order to be able to call a general meeting on less than 21 clear days' notice, the Company must make a means of electronic voting available to all shareholders for that meeting. Annual general meetings must continue to be held on at least 21 clear days' notice. This Resolution 22, proposed as a special resolution, seeks shareholder approval to have the ability to call general meetings (other than an annual general meeting) on not less than 14 clear days' notice. The power granted at the last annual general meeting to allow the Company to call general meetings (other than an annual general meeting) on 14 clear days' notice is due to expire at the Annual General Meeting. If granted, the approval will be effective until the Company's next annual general meeting, when it is intended that a similar resolution will be proposed.

The shorter notice period would not be used as a matter of routine, but only where the flexibility is merited by the business of the meeting and is thought to be in the interests of shareholders as a whole.

Definitions

The following definitions apply throughout this document and the accompanying Form of Proxy, unless the context otherwise requires:

"Act"	the Companies Act 2006, as amended;
"Annual General Meeting"	the annual general meeting of the Company convened for 10:00 am on 15 July 2026 (or any adjournment of it), notice of which is set out in this document;
"Annual Report and Accounts"	the annual report and accounts of the Company for the financial year ended 31 March 2026;
"Articles" or "Articles of Association"	the articles of association of the Company as at the date of this document;
"Board" or "Directors"	the directors of the Company;
"Company"	ICG PLC (incorporated in England and Wales No. 02234775);
"Computershare"	Computershare Investor Services plc (incorporated in England and Wales No. 03498808);
"CREST"	the UK-based central securities depository operated by Euroclear;
"Directors' Remuneration Policy"	the directors' remuneration policy set out in the Annual Report and Accounts;
"Directors' Remuneration Report"	the directors' remuneration report set out in the Annual Report and Accounts;
"Euroclear"	Euroclear UK & International Limited;
"Final Dividend"	the dividend of 59.3 pence per share for the financial year ended 31 March 2026 payable on 31 July 2026 to all shareholders on the register of members of the Company at the close of business on 12 June 2026;
"Form of Proxy"	the form of proxy relating to the Annual General Meeting being sent to shareholders with this document;
"Notice of Annual General Meeting" or "Notice"	the notice convening the Annual General Meeting as set out on pages 4 to 6 of this document;
"Resolution(s)"	the resolution(s) set out in the Notice of Annual General Meeting; and
"UK" or "United Kingdom"	the United Kingdom of Great Britain and Northern Ireland.

ICG

icgam.com